Accelerate Microbial Strain R&D with Benchling Solutions

KB at your finger tips

This is one stop global knowledge base where you can learn about all the products, solutions and support features.

Products-Benchling

Accelerate Microbial Strain R&D with Benchling Solutions

Introduction to Microbial Strain R&D Solution

In the realm of sustainable bio-based innovations, microbial strains play a crucial role in revolutionizing industries such as industrial biotech, food and beverage, sustainable materials, and consumer goods. The advancements in synthetic biology and metabolic engineering have paved the way for creating novel strains that enhance the sustainable production of proteins, small molecules, and cellular products. To expedite the development of optimal microbes, strain research teams are adopting sophisticated techniques like strain engineering, high-throughput fermentation screening, parallel bioprocessing, and analytical automation.

Benchling's Modern Digital Platform for Strain R&D

Benchling's Microbial Strain R&D Solutions offer a robust digital platform tailored to meet the specific needs of strain research and process development teams. This platform is designed to enhance data capture, streamline workflows, and provide valuable insights crucial for accelerating microbial strain R&D. Trusted by hundreds of innovators across various industries, Benchling leverages industry best practices to improve traceability of genes, plasmids, parts, and strains. Centralizing complex data from diverse automation technologies, Benchling helps in managing work requests, sample submissions, and results reporting efficiently.

Key Benefits and Capabilities of Benchling Solutions

With Benchling's solution, users can create and test novel strains on a connected platform that ensures end-to-end traceability by automatically linking related genetic components. The platform also enables orchestration of sample and data handoffs across teams, facilitating seamless collaboration and communication. Access to detailed insights across assays, experiments, and runs allows for consistent results capture and deeper understanding of strain performance and characteristics.

Customer Support and Expertise

Benchling provides dedicated expertise through Customer Experience professionals with a strong background in industrial biotechnology and information technology best practices. Customers can benefit from continuous oversight, pre-implementation solutions consulting, and professional implementation services to maximize the value derived from Benchling's platform. Moreover, focused R&D support in the form of implementation guides assists in various strain R&D functions, ensuring a seamless and efficient user experience.

Testimonials and Industry Recognition

Trusted by renowned organizations like Novozymes, Benchling has gained recognition as a powerful tool for advancing strain engineering, fermentation science, and overall biotechnology research. With over 200,000 scientists from Fortune 500 companies, startups, and academic institutions utilizing Benchling, the platform has successfully powered breakthroughs and innovations across the biotech landscape.

Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive seamless operations, and scale effortlessly for long-term success.

Book A Meeting To Setup A VDC

Revolutionizing In Vivo Studies with Benchling In Vivo

Optimizing In Vivo Studies with Benchling

Benchling's In Vivo solution offers a cutting-edge platform designed to revolutionize in vivo studies, enabling companies to manage these studies efficiently with modern software geared towards data capture, collaboration, and insights. This innovative tool ensures that teams can save time and generate accurate in vivo study data as part of their connected R&D process. With Benchling In Vivo, researchers can accelerate study startup, capture in-life study data, and drive collaboration effectively.

Read article

Revolutionizing Large Molecule Bioprocess Development with Benchling: A Case Study with Gilead Sciences

Introduction to Gilead Sciences and Benchling Partnership

Gilead Sciences, a renowned biopharmaceutical company dedicated to medical breakthroughs, partnered with Benchling to enhance large molecule bioprocess development. With a focus on novel therapies for life-threatening diseases, Gilead sought to bolster scientist productivity, collaboration, and data insights to elevate efficiency and predictability in their development processes.

Read article

Optimizing Agritech Research and Development with Benchling

The Importance of Agritech R&D in Revolutionizing Agriculture

Agricultural technology, or agritech, has become a key player in shaping modern farming practices. With the goal of increasing food security, reducing greenhouse gas emissions, and utilizing natural resources efficiently, agritech R&D plays a crucial role in driving innovation within the agricultural industry. To achieve these breakthroughs, research and development teams require sophisticated informatics tools that can integrate data across various domains, including chemistry, genomics, and sample tracking.

Read article

Revolutionizing Antibody and Protein R&D with Benchling Solutions

The Evolution of Antibody R&D

The field of antibodies and proteins is witnessing a transformative era in the fight against critical illnesses like cancer and immune system disorders. Innovations in monoclonal antibody technology, bispecifics, and antibody-drug conjugates are paving the way for more effective treatments with enhanced safety profiles. Antibody research and development (R&D) teams are embracing diverse formats, integrating cutting-edge technologies such as Next-Generation Sequencing (NGS) and CRISPR, and automating key processes to drive the development of groundbreaking antibodies.

Read article

ElevateBio: Revolutionizing Cell and Gene Therapy Research with Benchling's Digital Solutions

Transforming Infrastructure for Optimal CGT Development Processes

Cell and gene therapies (CGTs) are paving the way for advanced disease treatments and personalized medicines, with several already gaining FDA approval. However, one major challenge faced by CGT companies is the inefficiencies in their infrastructure, hindering the development of life-saving therapeutics. ElevateBio recognized these bottlenecks and set out to revolutionize CGT development by leveraging a groundbreaking solution. Through Benchling's integrated technologies model, ElevateBio is empowering the acceleration of design, manufacturing, and development of various genetic medicines. This unique platform offers turnkey scale and biotechnological capabilities, enabling CGT processes and programs to reach their full potential.

Read article

Welcome to Knowledge Base!

KB at your finger tips

Products-Benchling